Sfxn5 | sideroflexin 5
Physiological systems
17 / 24 physiological systems tested
2 Significantly impacted by the knock-out
Homeostasis/metabolism Behavior/neurological
15 No significant impact
7 Not tested
Data collections
Gene metrics:2Significant phenotypes
0Associated diseases
Expression examined in:48Adult tissues
50Embryo tissues
decreased fasting circulating glucose level | 1 supporting dataset | Sfxn5tm1b(EUCOMM)Hmgu | heterozygote | Early adult | 0 | ||
increased grip strength | 1 supporting dataset | Sfxn5tm1b(EUCOMM)Hmgu | heterozygote | Early adult | 4.23x10-5 |
| | | | | | | | | |
External links
No external links available for Sfxn5.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Sfxn5tm1a(EUCOMM)Hmgu | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell mouse |
Sfxn5tm1b(EUCOMM)Hmgu | Reporter-tagged deletion allele (with selection cassette) | | mouse |
Sfxn5tm1e(EUCOMM)Hmgu | Targeted, non-conditional allele | | ES Cell |